Lead Story Picture
A woman who sued Eli Lilly claims withdrawal symptoms for Cymbalta range from electric-shock sensations in the body and brain, known as “brain zaps,” to dizziness, nausea, vomiting, vertigo, excessive sweating, insomnia, nightmares and diarrhea. (Credit: AP)

Eli Lilly Hid Cymbalta Risks, Jury Told As Bellwether Opens

Counsel for a woman alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta told a California federal jury during opening statements in the bellwether trial Tuesday that the drugmaker's own study revealed almost half of patients who stopped taking the drug risked withdrawal symptoms.

  • Judge Trims Libor Claims Against Banks In NY Lawsuits

    Credit Suisse and Citigroup came out the biggest winners in the latest major ruling on claims that the world’s biggest banks manipulated the London Interbank Offered Rate, as each was dismissed from five suits in New York federal court in a sprawling 430-page opinion.

  • AmEx Judge Rejects Merchant Deal Over Atty 'Collusion'

    A New York federal judge on Tuesday rejected a proposed class action settlement in the antitrust litigation merchants brought against American Express Co., saying the frequent exchange of confidential information that one of the lead plaintiffs' attorneys shared with counsel for MasterCard Inc. "smacks of blatant collusion."

  • Faruqi, Ex-Lawyer Settle 2nd Circ. Sex Harassment Row

    Faruqi & Faruqi LLP and former associate Alexandra Marchuk, who won a $140,000 judgment in her sexual harassment suit against the firm, agreed to settle their dispute at the Second Circuit, a few months after the parties filed cross-appeals following the jury trial that left neither side pleased with the outcome.

  • House Ethics Panel To Probe Pa. Rep. Following Indictment

    The U.S. House of Representatives’ Ethics Committee on Monday said it is opening an investigation into whether Congressman Chaka Fattah Sr., D-Pa., violated House rules in light of bribery and fraud charges filed in connection with his failed Philadelphia mayoral bid.

  • Bayer Agrees To $57M Deal To End Yaz Blood Clot Suits

    Bayer Corp. has agreed to pay nearly $57 million to end a series of lawsuits across multiple federal and state jurisdictions over allegations that use of its birth control pills Yaz, Yasmin and Ocella resulted in strokes and heart attacks.

  • Record $1.5B Marvell Verdict Slashed To $278M By Fed. Circ.

    The Federal Circuit on Tuesday significantly reduced the record $1.54 billion judgment that Carnegie Mellon University won against Marvell Technology Group Ltd. in a disk drive patent suit, leaving $278 million in damages intact and ordering a new trial to recalculate the remaining amount.


Follow our exclusive coverage of the trial of the year:

Catch up on the Dewey trial here